Hudson BD

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (2)

Title : From structure to clinic: Design of a muscarinic M1 receptor agonist with potential to treatment of Alzheimer's disease - Brown_2021_Cell_184_5886
Author(s) : Brown AJH , Bradley SJ , Marshall FH , Brown GA , Bennett KA , Brown J , Cansfield JE , Cross DM , de Graaf C , Hudson BD , Dwomoh L , Dias JM , Errey JC , Hurrell E , Liptrot J , Mattedi G , Molloy C , Nathan PJ , Okrasa K , Osborne G , Patel JC , Pickworth M , Robertson N , Shahabi S , Bundgaard C , Phillips K , Broad LM , Goonawardena AV , Morairty SR , Browning M , Perini F , Dawson GR , Deakin JFW , Smith RT , Sexton PM , Warneck J , Vinson M , Tasker T , Tehan BG , Teobald B , Christopoulos A , Langmead CJ , Jazayeri A , Cooke RM , Rucktooa P , Congreve MS , Weir M , Tobin AB
Ref : Cell , 184 :5886 , 2021
Abstract : Brown_2021_Cell_184_5886
ESTHER : Brown_2021_Cell_184_5886
PubMedSearch : Brown_2021_Cell_184_5886
PubMedID: 34822784

Title : The pharmacology of TUG-891, a potent and selective agonist of the free fatty acid receptor 4 (FFA4\/GPR120), demonstrates both potential opportunity and possible challenges to therapeutic agonism - Hudson_2013_Mol.Pharmacol_84_710
Author(s) : Hudson BD , Shimpukade B , Mackenzie AE , Butcher AJ , Pediani JD , Christiansen E , Heathcote H , Tobin AB , Ulven T , Milligan G
Ref : Molecular Pharmacology , 84 :710 , 2013
Abstract : Hudson_2013_Mol.Pharmacol_84_710
ESTHER : Hudson_2013_Mol.Pharmacol_84_710
PubMedSearch : Hudson_2013_Mol.Pharmacol_84_710
PubMedID: 23979972